Image For Activity Cover
Redefining the Classifications of Response to Cardiac Resynchronization Therapy: Results From the REVERSE Study - JCEP July 2021
Redefining the Classifications of Response to Cardiac Resynchronization Therapy: Results From the REVERSE Study - JCEP July 2021
Cardiac resynchronization therapy (CRT) improves functional status and outcomes in selected populations with heart failure (HF). However, approximately 30% of patients do not improve with CRT by various metrics, and they are traditionally classified as nonresponders. This study sought to assess the impact of a more detailed classification of response on survival.

Editor-in-Chief
Kalyanam Shivkumar, MD, PhD, FACC 

CME Editor
Kenneth A. Ellenbogen, MD

Author
Kenneth A. Ellenbogen, MD

Important Dates
Date of Release: July 19, 2021  
Term of Approval/Date of CME/MOC/ECME Expiration: July 18, 2022
Summary
Availability: On-Demand
Expires on Jul 18, 2022
Cost: FREE
Credit Offered:
1 CME Credit
1 ABIM-MOC Point
1 ECME Credit
Android App Download IOS App Download Powered By